On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D000873:Anthracenes / Q000494:pharmacology; D003024:Clozapine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects*; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D008032:Limbic System / Q000187:drug effects*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D011618:Psychotic Disorders / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000494:pharmacology*; D051381:Rats; D013469:Sulpiride / Q000494:pharmacology; D013881:Thioridazine / Q000494:pharmacology
D000873:Anthracenes; D008781:Methyltyrosines; D011619:Psychotropic Drugs; D015102:3,4-Dihydroxyphenylacetic Acid; D013469:Sulpiride; D003024:Clozapine; D006220:Haloperidol; D013881:Thioridazine; D004298:Dopamine; D006719:Homovanillic Acid